Genomics

Towards our Genomics Ambition

Participating in one of the most ambitious sequencing programmes ever undertaken

The Whole Genome Sequencing (WGS) project's long-term aim is to enable the scientific community to better understand, diagnose, treat and prevent life-changing diseases, such as cancer and diabetes.
Corporate Press Release

Imfinzi is first immunotherapy to show both significant survival benefit and improved, durable responses in extensive-stage small cell lung cancer

Corporate Press Release

Tagrisso approved in China as a 1st-line treatment for EGFR-mutated non-small cell lung cancer

Corporate Press Release

Brilinta reduced the risk of cardiovascular events in patients with coronary artery disease and type-2 diabetes in Phase III THEMIS trial

Corporate Press Release

Detailed results from Phase III DAPA-HF trial showed Farxiga significantly reduced both the incidence of cardiovascular death and the worsening of heart failure

Publications

Our innovative science means a strong track-record of publication in peer-reviewed journals, contributing to the foundation of scientific advancement.

View our publications

Our science

At AstraZeneca, science is at the core of everything we do. But more than that, science is who we are.

Find out more